K242125

Substantially Equivalent

Elvie Stride 2

Applicant: Chiaro Technology, Ltd.
Product code: HGX
Advisory panel: Obstetrics/Gynecology
Date received: 2024-07-19
Decision date: 2024-09-27
Decision: Substantially Equivalent
Clearance type: Special
Location: London, GB

Adverse events under product code HGX

product code HGX

Injury: 758
Other: 2
Total: 760

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.